2016
C. B. Malpas, Vivash, L., Genc, S., Saling, M. M., Desmond, P., Steward, C., Hicks, R. J., Callahan, J., Brodtmann, A., Collins, S., Macfarlane, S., Corcoran, N. M., Hovens, C. M., Velakoulis, D., and O'Brien, T. J.,
“A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.”,
J Alzheimers Dis, vol. 54, no. 1, pp. 223-32, 2016.
C. B. Malpas, Vivash, L., Genc, S., Saling, M. M., Desmond, P., Steward, C., Hicks, R. J., Callahan, J., Brodtmann, A., Collins, S., Macfarlane, S., Corcoran, N. M., Hovens, C. M., Velakoulis, D., and O'Brien, T. J.,
“A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.”,
J Alzheimers Dis, vol. 54, no. 1, pp. 223-32, 2016.
C. B. Malpas, Vivash, L., Genc, S., Saling, M. M., Desmond, P., Steward, C., Hicks, R. J., Callahan, J., Brodtmann, A., Collins, S., Macfarlane, S., Corcoran, N. M., Hovens, C. M., Velakoulis, D., and O'Brien, T. J.,
“A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.”,
J Alzheimers Dis, vol. 54, no. 1, pp. 223-32, 2016.
S. Kang, Jeong, H., Baek, J. - H., Lee, S. - J., Han, S. - H., Cho, H. Jin, Kim, H., Hong, H. Seok, Kim, Y. Ho, Yi, E. C., Seo, S. Won, Na, D. L., Hwang, D., and Mook-Jung, I.,
“PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.”,
J Alzheimers Dis, vol. 53, no. 4, pp. 1563-76, 2016.
H. K. Mohseni, Cowan, D., Chettle, D. R., Milić, A. Pejović, Priest, N., Matysiak, W., Atanackovic, J., Byun, S. Hyun, and Prestwich, W. V.,
“A Pilot Study Measuring Aluminum in Bone in Alzheimer's Disease and control Subjects Using in vivo Neutron Activation Analysis.”,
J Alzheimers Dis, vol. 53, no. 3, pp. 933-42, 2016.
H. K. Mohseni, Cowan, D., Chettle, D. R., Milić, A. Pejović, Priest, N., Matysiak, W., Atanackovic, J., Byun, S. Hyun, and Prestwich, W. V.,
“A Pilot Study Measuring Aluminum in Bone in Alzheimer's Disease and control Subjects Using in vivo Neutron Activation Analysis.”,
J Alzheimers Dis, vol. 53, no. 3, pp. 933-42, 2016.
N. Marchesi, Amadio, M., Colombrita, C., Govoni, S., Ratti, A., and Pascale, A.,
“PKC Activation Counteracts ADAM10 Deficit in HuD-Silenced Neuroblastoma Cells.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 535-47, 2016.
P. Chatterjee, Lim, W. L. F., Shui, G., Gupta, V. B., James, I., Fagan, A. M., Xiong, C., Sohrabi, H. R., Taddei, K., Brown, B. M., Benzinger, T., Masters, C., Snowden, S. G., Wenk, M. R., Bateman, R. J., Morris, J. C., and Martins, R. N.,
“Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study.”,
J Alzheimers Dis, vol. 50, no. 3, pp. 887-94, 2016.
D. Galimberti, Bertram, K., Formica, A., Fenoglio, C., Cioffi, S. M. G., Arighi, A., Scarpini, E., and Colosimo, C.,
“Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.”,
J Alzheimers Dis, vol. 53, no. 2, pp. 445-9, 2016.
D. Galimberti, Bertram, K., Formica, A., Fenoglio, C., Cioffi, S. M. G., Arighi, A., Scarpini, E., and Colosimo, C.,
“Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.”,
J Alzheimers Dis, vol. 53, no. 2, pp. 445-9, 2016.
I. Luccarini, Pantano, D., Nardiello, P., Cavone, L., Lapucci, A., Miceli, C., Nediani, C., Berti, A., Stefani, M., and Casamenti, F.,
“The Polyphenol Oleuropein Aglycone Modulates the PARP1-SIRT1 Interplay: An In Vitro and In Vivo Study.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 737-50, 2016.
I. Luccarini, Pantano, D., Nardiello, P., Cavone, L., Lapucci, A., Miceli, C., Nediani, C., Berti, A., Stefani, M., and Casamenti, F.,
“The Polyphenol Oleuropein Aglycone Modulates the PARP1-SIRT1 Interplay: An In Vitro and In Vivo Study.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 737-50, 2016.
R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S.,
“Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.”,
J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.
H. E. Barry, Cooper, J. A., Ryan, C., A Passmore, P., A Robinson, L., Molloy, G. J., Darcy, C. M., Buchanan, H., and Hughes, C. M.,
“Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database.”,
J Alzheimers Dis, vol. 52, no. 4, pp. 1503-13, 2016.
L. Xu, Wu, X., Li, R., Chen, K., Long, Z., Zhang, J., Guo, X., and Yao, L.,
“Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.”,
J Alzheimers Dis, vol. 51, no. 4, pp. 1045-56, 2016.
B. Yoon, Shim, Y. S., Park, H. - K., Park, S. Ah, Choi, S. Hye, and Yang, D. Won,
“Predictive factors for disease progression in patients with early-onset Alzheimer's disease.”,
J Alzheimers Dis, vol. 49, no. 1, pp. 85-91, 2016.
M. H. Connors, Ames, D., Boundy, K., Clarnette, R., Kurrle, S., Mander, A., Ward, J., Woodward, M., and Brodaty, H.,
“Predictors of Mortality in Dementia: The PRIME Study.”,
J Alzheimers Dis, vol. 52, no. 3, pp. 967-74, 2016.
M. H. Connors, Ames, D., Boundy, K., Clarnette, R., Kurrle, S., Mander, A., Ward, J., Woodward, M., and Brodaty, H.,
“Predictors of Mortality in Dementia: The PRIME Study.”,
J Alzheimers Dis, vol. 52, no. 3, pp. 967-74, 2016.
R. A. Stern, Tripodis, Y., Baugh, C. M., Fritts, N. G., Martin, B. M., Chaisson, C., Cantu, R. C., Joyce, J. A., Shah, S., Ikezu, T., Zhang, J., Gercel-Taylor, C., and Taylor, D. D.,
“Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy.”,
J Alzheimers Dis, vol. 51, no. 4, pp. 1099-109, 2016.
R. A. Stern, Tripodis, Y., Baugh, C. M., Fritts, N. G., Martin, B. M., Chaisson, C., Cantu, R. C., Joyce, J. A., Shah, S., Ikezu, T., Zhang, J., Gercel-Taylor, C., and Taylor, D. D.,
“Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy.”,
J Alzheimers Dis, vol. 51, no. 4, pp. 1099-109, 2016.
E. Oldoni, Fumagalli, G. G., Serpente, M., Fenoglio, C., Scarioni, M., Arighi, A., Bruno, G., Talarico, G., Confaloni, A., Piscopo, P., Nacmias, B., Sorbi, S., Rainero, I., Rubino, E., Pinessi, L., Binetti, G., Ghidoni, R., Benussi, L., Grande, G., Arosio, B., Bursey, D., Kauwe, J. S., Cioffi, S. Mg, Arcaro, M., Mari, D., Mariani, C., Scarpini, E., and Galimberti, D.,
“PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.”,
J Alzheimers Dis, vol. 50, no. 2, pp. 353-7, 2016.
E. Oldoni, Fumagalli, G. G., Serpente, M., Fenoglio, C., Scarioni, M., Arighi, A., Bruno, G., Talarico, G., Confaloni, A., Piscopo, P., Nacmias, B., Sorbi, S., Rainero, I., Rubino, E., Pinessi, L., Binetti, G., Ghidoni, R., Benussi, L., Grande, G., Arosio, B., Bursey, D., Kauwe, J. S., Cioffi, S. Mg, Arcaro, M., Mari, D., Mariani, C., Scarpini, E., and Galimberti, D.,
“PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.”,
J Alzheimers Dis, vol. 50, no. 2, pp. 353-7, 2016.
F. Bermejo-Pareja, Contador, I., Trincado, R., Lora, D., Sánchez-Ferro, Á., Mitchell, A. J., Boycheva, E., Herrero, A., Hernández-Gallego, J., Llamas, S., Galende, A. Villarejo, and Benito-León, J.,
“Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort.”,
J Alzheimers Dis, vol. 50, no. 3, pp. 719-31, 2016.
E. Morenas-Rodriguez, Cervera-Carles, L., Vilaplana, E., Alcolea, D., Carmona-Iragui, M., Dols-Icardo, O., Ribosa-Nogué, R., Muñoz-Llahuna, L., Sala, I., M Sánchez-Saudinós, B., Blesa, R., Clarimón, J., Fortea, J., and Lleo, A.,
“Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.”,
J Alzheimers Dis, vol. 50, no. 2, pp. 539-46, 2016.
E. Morenas-Rodriguez, Cervera-Carles, L., Vilaplana, E., Alcolea, D., Carmona-Iragui, M., Dols-Icardo, O., Ribosa-Nogué, R., Muñoz-Llahuna, L., Sala, I., M Sánchez-Saudinós, B., Blesa, R., Clarimón, J., Fortea, J., and Lleo, A.,
“Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.”,
J Alzheimers Dis, vol. 50, no. 2, pp. 539-46, 2016.
] 